Félix Couture

Boulanger J, Ducharme A, Dufour A, Fortier S, Almanric K, ,

Management of the extravasation of anti-neoplastic agents

Support Care Cancer, 23 (5), 2015.

Résumé | Liens:

Chen S, Villeneuve L, Jonker D, Couture F, Laverdiere I, Cecchin E, Innocenti F, Toffoli G, Levesque E, Guillemette C

ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients

Pharmacogenet Genomics, 25 (12), 2015.

Résumé | Liens:

Boily G, Villeneuve JP, Lacoursiere L, Chaudhury P, Couture F, Ouellet JF, Lapointe R, Goulet S, Gervais N,

Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations

HPB (Oxford), 17 (1), 2015.

Résumé | Liens:

Iliuta IA, Beauregard JM, Couture F, Douville P, Mac-Way F

Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas

Clin Nucl Med, 40 (9), 2015.

Résumé | Liens:

Chen S, Laverdiere I, Tourancheau A, Jonker D, Couture F, Cecchin E, Villeneuve L, Harvey M, Court MH, Innocenti F, Toffoli G, Levesque E, Guillemette C

A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients

Pharmacogenomics J, 15 (6), 2015.

Résumé | Liens:

Laverdiere I, Guillemette C, Tamouza R, Loiseau P, Peffault de Latour R, Robin M, Couture F, Filion A, Lalancette M, Tourancheau A, Charron D, Socie G, Levesque E

Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease

Haematologica, 100 (2), 2015.

Résumé | Liens:

Villa D, George A, Seymour JF, Toze CL, Crump M, Lee C, Buckstein R, Stewart DA, MacDonald D, Foley R, Xenocostas A, Sabloff M, Chua N, Couture F, Larouche JF, Cohen S, Savage KJ, Connors JM, Panzarella T, Carney DA, Dickinson M, Kuruvilla J

Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma

Biol Blood Marrow Transplant, 20 (11), 2014.

Résumé | Liens:

Villa D, Crump M, Panzarella T, Savage KJ, Toze CL, Stewart DA, Macdonald DA, Buckstein R, Lee C, Alzahrani M, Rubinger M, Foley R, Xenocostas A, Sabloff M, Muccilli A, Chua N, Couture F, Larouche JF, Cohen S, Connors JM, Ambler K, Al-Tourah A, Ramadan KM, Kuruvilla J

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group

J Clin Oncol, 31 (9), 2013.

Résumé | Liens:

Bormanis J, Quirt I, Chang J, Kouroukis CT, MacDonald D, Melosky B, Verma S, Couture F

Erythropoiesis-stimulating agents (ESAs): do they still have a role in chemotherapy-induced anemia (CIA)?

Crit Rev Oncol Hematol, 87 (2), 2013.

Résumé | Liens:

Morneau M, Foster W, Lalancette M, Van Nguyen-Huynh T, Renaud MC, Samouelian V, Letarte N, , Almanric K, Boily G, Bouchard P, Boulanger J, Cournoyer G, Couture F, Gervais N, Goulet S, Guay MP, Kavanagh M, Lemieux J, Lesperance B, Ouellet JF, Pineau G, Rajan R, Roy I, Samson B, Sideris L, Vincent F

Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO)

Gynecol Oncol, 131 (1), 2013.

Résumé | Liens: